2796
T. Hammerer et al.
PAPER
EtOH, 3 mL) to give the pure product as an orange solid; yield:
394.4 mg (0.79 mmol, 78%).
[α]D24 +71.6 (c 0.393, CH2Cl2).
iridium-catalyzed asymmetric hydrogenation of an imine
and enantioselectivities of up to 74% ee have been ob-
tained with the matched diastereomer L1.
1H NMR (400 MHz, C6D6): δ = 0.97–1.04 (m, 1 H, CH2), 1.10 (dd,
J
H,H = 6.9 Hz, JH,P = 17.3 Hz, 3 H, CH3), 1.16–1.25 (br m, 1 H, CH),
All reactions were carried out under an inert atmosphere of dry and
O2-free argon either with the use of standard Schlenk techniques or
1.20 (t, JH,H,P = 7.1 Hz, 3 H, CH3), 1.31 (dd, JH,H = 7.4 Hz, JH,P = 18.7
Hz, 3 H, CH3), 1.42 (dd, JH,H = 7.3 Hz, JH,P = 10.4 Hz, 3 H,
CH3),1.47–1.61 (br m, 1 H, CH2), 1.67–1.77 (br m, 1 H, CH2), 1.69
(dd, JH,H = 7.0 Hz, JH,P = 15.1 Hz, 3 H, CH3), 1.79–1.87 (m, 2 H, CH
+ CH2), 1.90–2.06 (br m, 4 H, 2 CH + 2 CH2), 2.09–2.17 (m, 1 H,
CH2), 2.37–2.52 (m, 1 H, CH2), 2.92–3.02 (m, 1 H, CH), 3.88–3.96
(m, 1 H, CCpH), 3.99–4.08 (m, 1 H, CCpH), 4.12 (s, 5 H, CCpH), 4.42
(s, 1 H, CCpH).
1
in a glove box. H, 13C, and 31P NMR spectra were recorded with
Bruker AV 300 spectrometer operating at 300.1 MHz (1H), 75.5
MHz (13C), and 121.5 MHz (31P) and Bruker AV 400 spectrometer
operating at 400.1 MHz (1H), 100 MHz (13C), and 162 MHz (31P);
1H and 13C{1H} NMR are relative to TMS with use of the residual
solvent signals as internal standards and 31P NMR are relative to
85% H3PO4 as external standard. The multiplicities of the signals
were analyzed by assuming spectra of first order. The signals were
13C NMR (101 MHz, C6D6): δ = 15.6 (CH3), 15.9 (CH3), 21.6 (d,
J
1
assigned on the basis of 2D NMR spectra (31P-1H HMBC, H-1H
C,P = 31.6 Hz, CH3), 22.1 (d, JC,P = 31.0 Hz, CH3), 25.0 (CH3), 25.3
COSY, 13C-1H HMBC, 13C-1H HSQC). Mass spectra were recorded
on a Varian 1200L Quadrupole GC-MS, Finnigan MAT 8200 (MS
and HRMS-EI) or a Bruker FTICR-Apex III spectrometer (HRMS-
ESI). HRMS were performed with a Finnigan-MAT 95 spectrome-
ter (EI, 70 eV). Optical rotations were measured on a Jasco P-1020
polarimeter. The concentrations used for measuring specific rota-
tions are given as g/100 mL. Toluene was dried over alumina with
a solvent purification system from Innovative Technology. Et2O,
MeOH, and EtOH were distilled and then dried over molecular
sieves. All other organic solvents were purged with argon for 2 h
prior to use. Deuterated solvents were degassed through freeze–
pump–thaw cycles and stored over molecular sieves. Compounds
2,10 3,8 and 48 were synthesized according to literature procedures.
All other chemicals were purchased from Sigma-Aldrich, Acros, or
Alfa Aesar and used as received.
(CH), 34.1 (CH), 34.9 (d, JC,P = 12.7 Hz, CH), 35.8 (d, JC,P = 8.1 Hz,
CH), 35.9 (CH2), 36.8 (CH2), 37.5 (CH2), 38.1 (d, JC,P = 3.6 Hz,
CH2), 38.6 (CH), 68.5 (CCpH), 68.9 (CCpH), 69.9 (5 CCpH), 71.3 (d,
J
C,P = 4.6 Hz, CCpH); the quaternary C-atoms of the Cp rings could
not be detected.
31P{1H} NMR (162 MHz, C6D6): δ = –2.0 (o-P), 24.1 (α-P).
HRMS (EI): m/z [M]+ calcd for C24H36FeP2: 442.16362; found:
442.16366.
(RFc)-1-[(2R,5R)-2,5-Dimethylphospholan-1-yl]-2-{(S)-1-
[(2R,5R)-2,5-dimethylphospholan-1-yl]ethyl}ferrocene
{(SC,RFc)-[C5H5]Fe[C5H3(CHMe{(R,R)-DMP}){(R,R)-DMP}],
L2}
The title compound was obtained as an orange solid starting from
(SC,RFc)-4 using the procedure described for L1; yield: 320.8 mg
(0.73 mmol, 74%).
(SFc)-2-[(R)-1-(Dimethylamino)ethyl]-1-[(2R,5R)-2,5-dimethyl-
phospholan-1-yl]ferrocene
[α]D24 +266.8 (c 0.393, CH2Cl2).
{(RC,SFc)[C5H5]Fe[C5H3(CHMeNMe2){(R,R)-DMP}], (RC,SFc)-
1H NMR (400 MHz, C6D6): δ = 1.04 (m, 1 H, CH2), 1.11 (dd, JH,H
=
4}8
7.1 Hz, JH,P = 17.1 Hz, 3 H, CH3), 1.16 (dd, JH,H = 7.2 Hz, JH,P = 9.1
Hz, 3 H, CH3), 1.19–1.23 (br m, 1 H, CH), 1.26 (dd, JH,H = 7.4 Hz,
A 1.5 M t-BuLi in pentane soln (1.01 mL, 1.51 mmol) was added at
–78 °C over 30 min through a syringe pump to a soln of (–)-(R)-
N,N-dimethyl-1-ferrocenylethylamine (Ugi-amine, 312.2 mg, 1.21
mmol, 1.0 equiv) in Et2O (10 mL). After stirring the soln at r.t. for
1 h, (2R,5R)-1-chloro-2,5-dimethylphospholane (3, 219.4 mg, 1.46
mmol, 1.2 equiv) was added and the resulting mixture heated to re-
flux for 2.5 h. The mixture was filtered through a short pad of Celite
and the solvent removed under reduced pressure. The pure product
was obtained as an orange solid after recrystallization (hot MeOH,
2 mL); yield: 356.4 mg (1.0 mmol, 81%).
J
H,P = 8.7 Hz, 3 H, CH3), 1.31–1.37 (m, 1 H, CH2), 1.48 (dd, JH,H =
7.3 Hz, JH,P = 19.1 Hz, 3 H, CH3), 1.49 (dd, JH,H = 4.4 Hz, JH,P = 7.0
Hz, 3 H, CH3), 1.52–1.58 (br m, 1 H, CH2), 1.76 (m, 1 H, CH2),
1.85–1.97 (br m, 2 H, CH2), 2.00–2.10 (br m, 2 H, CH2), 2.10–2.19
(m, 1 H, CH), 2.20–2.37 (m, 1 H, CH), 2.59–2.73 (m, 1 H, CH),
3.39–3.49 (m, 1 H, CH), 3.84–3.92 (m, 1 H, CCpH), 4.06 (s, 1 H,
CCpH), 4.07–4.14 (m, 1 H, CCpH), 4.12 (s, 5 H, CCpH).
13C NMR (101 MHz, C6D6): δ = 14.7 (CH3), 17.8 (d, JC,P = 14.7 Hz,
CH3), 18.7 (CH3), 21.4 (d, JC,P = 33.0 Hz, CH3), 22.6 (d, JC,P = 37.3
1H NMR (400 MHz, C6D6): δ = 1.13 (d, JH,P = 6.7 Hz, 3 H, CH3),
1.21 (m, 1 H, CH2), 1.37 (dd, JH,H = 7.1 Hz, JH,P = 18.9 Hz, 3 H,
CH3), 1.54 (dd, JH,H = 7.7 Hz, JH,P = 2.3 Hz, 3 H, CH3), 1.74–1.87
(m, 1 H, CH2), 1.88–2.01 (m, 1 H, CH2), 2.10 (s, 6 H, 2 CH3), 2.09–
2.20 (br m, 3 H, CH, CH2), 3.95 (br s, 1 H, CHCp), 3.90–4.05 (m, 6
H, CHCp), 4.08 (br s, 1 H, CHCp), 4.14–4.25 (m, 1 H, CH).
Hz, CH3), 26.7 (CH), 30.7 (d, JC,P = 17.7 Hz, CH), 35.8 (d, JC,P
=
11.8 Hz, CH), 36.1 (d, JC,P = 17.6 Hz, CH), 36.5 (CH2), 36.8 (d,
J
J
C,P = 8.7 Hz, CH), 37.4 (CH2), 37.6 (d, JC,P = 2.5 Hz, CH2), 38.2 (d,
C,P = 3.8 Hz, CH2), 68.0 (CCpH), 68.5 (CCpH), 69.2 (5 CCpH), 70.8
(d, JC,P = 6.4 Hz, CHCp), 75.7 (CCp), 102.1 (CCp).
31P{1H} NMR (162 MHz, C6D6): δ = –11.6 (d, JP,P = 23.3 Hz, o-P),
16.6 (d, JP,P = 23.3 Hz, α-P).
HRMS (EI): m/z [M]+ calcd for C24H36FeP2: 442.16362; found:
13C NMR (101 MHz, C6D6): δ = 7.4 (CH3), 16.1 (CH3), 21.7 (d,
JC,P = 30.8 Hz, CH3), 36.1 (d, JC,P = 11.4 Hz, CH), 37.0 (d, JC,P = 3.8
Hz, CH2), 38.2 (d, JC,P = 5.2 Hz, CH2), 39.2 (2 CH3), 41.6 (d, JC,P
=
442.16338.
9.8 Hz, CH), 57.0 (d, JC,P = 8.7 Hz, CH), 67.9 (CHCp), 68.5 (CHCp),
70.2 (5 CHCp), 72.2 (d, JC,P = 4.7 Hz, CHCp), 79.4 (d, JC,P = 32.7 Hz,
CCp), 96.1 (d, JC,P = 19.2 Hz, CCp).
31P{1H} NMR (162 MHz, C6D6): δ = –5.8.
Selenide Formation; General Procedure
Bisselenides of L1 and L2 were prepared by treating a NMR sample
of the bisphospholanes with an excess of elemental Se for 2 h at 60
°C in C6D6. For spectroscopic data see Table 5.
(SFc)-1-[(2R,5R)-2,5-Dimethylphospholan-1-yl]-2-{(R)-1-
[(2R,5R)-2,5-dimethylphospholan-1-yl]ethyl}ferrocene
{(RC,SFc)-[C5H5]Fe[C5H3(CHMe{(R,R)-DMP}){(R,R)-DMP}],
L1}
(2R,5R)-2,5-Dimethylphospholane (117.6 mg, 1.01 mmol, 1 equiv)
was added to a soln of (RC,SFc)-4 (374.1 mg, 1.01 mmol, 1 equiv) in
glacial AcOH (5 mL) and heated to reflux for 2 h. The solvent was
removed in vacuo and the resulting solid was recrystallized (hot
Asymmetric C=N-Hydrogenation; General Procedure
A 10-mL stainless steel autoclave equipped with a glass inlet and a
magnetic stirring bar was charged under an argon atmosphere with
the imine 5 (0.5 mmol) and I2 (0.025 mmol). A Schlenk flask
equipped with magnetic stirring bar was charged with [Ir(cod)Cl]2
(1.68 mg, 2.5 μmol), the desired ligand L1 or L2 (5.5 μmol), and
toluene (2 mL). After 10 min under stirring, the resulting soln was
Synthesis 2012, 44, 2793–2797
© Georg Thieme Verlag Stuttgart · New York